
Hematologist-Oncologist

No OPD information available
Blood Clots
Hemophilia A
Acute Myeloid Leukemia (AML)
Acute Promyelocytic Leukemia
Gray Platelet Syndrome
Hemolytic Transfusion Reaction
Leukemia
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Multiple Myeloma
Smoldering Multiple Myeloma
T-Cell Lymphoma
Liane P. Khoo is a female medical professional who helps patients with various health conditions like blood clots, leukemia, and lymphoma. She specializes in treating diseases like Hemophilia A, Acute Myeloid Leukemia (AML), and Multiple Myeloma. Liane uses special skills and treatments to care for her patients and make them feel better.
Patients trust Liane because she communicates well with them, explaining things clearly and listening to their concerns. She is kind and compassionate, which helps patients feel comfortable and cared for during their treatment. Liane stays updated with the latest medical knowledge and research to provide the best care possible to her patients.
Liane works closely with other medical professionals, building good relationships with her colleagues. She believes in teamwork and collaboration to ensure that patients receive the best care from a group of experts. Her approach to working with others helps her patients get the most comprehensive treatment possible.
Liane's work has had a positive impact on many patients' lives. She has helped improve their health and quality of life through her expertise and dedication. Her research publications, like the study on oral arsenic trioxide for APL treatment, and participation in clinical trials, such as the ADVATE/ADYNOVI Hemophilia A Outcome Database, show her commitment to advancing medical knowledge and improving patient care.
In summary, Liane P. Khoo is a skilled and caring medical professional who goes above and beyond to help her patients and contribute to medical research. Her dedication to staying informed, working well with colleagues, and making a positive impact on patients' lives sets her apart as a trusted and respected healthcare provider.
Enrollment Status: Completed
Published: June 17, 2024
Intervention Type: Biological
Study Drug:
Study Phase:
